About the response against AIDS, TB and Malaria

Stop TB Partnership and Johnson & Johnson, with support fromUSAID and The Global Fund, Announce Price Reduction for bedaquiline for Treatment of DR-TB in Low- and Middle-Income Countries

Source: http://www.stoptb.org

Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19 pandemic
In 2020,